Palisade Bio (PALI) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.77% |
| Dec 31, 2025 | 113.63% |
| Sep 30, 2025 | -14.40% |
| Jun 30, 2025 | -17.17% |
| Mar 31, 2025 | -6.34% |
| Dec 31, 2024 | 10.57% |
| Sep 30, 2024 | 0.86% |
| Jun 30, 2024 | 29.59% |
| Mar 31, 2024 | 18.54% |
| Dec 31, 2023 | 12.83% |
| Sep 30, 2023 | 17.19% |
| Jun 30, 2023 | 14.65% |
| Mar 31, 2023 | 5.73% |
| Dec 31, 2022 | 2.57% |
| Sep 30, 2022 | 0.10% |
| Jun 30, 2022 | -10.07% |
| Mar 31, 2022 | -14.92% |
| Dec 31, 2021 | -11.16% |
| Sep 30, 2021 | 14.00% |
| Jun 30, 2021 | 2.37% |
| Mar 31, 2021 | -2.66% |
| Dec 31, 2020 | -27.38% |
| Sep 30, 2020 | -6.42% |
| Jun 30, 2020 | -8.30% |
| Mar 31, 2020 | -18.08% |
| Dec 31, 2019 | -26.09% |
| Sep 30, 2019 | -21.20% |
| Jun 30, 2019 | -35.93% |
| Mar 31, 2019 | -31.53% |
| Dec 31, 2018 | -16.92% |
| Sep 30, 2018 | -16.63% |
| Jun 30, 2018 | -7.72% |
| Mar 31, 2018 | -5.61% |
| Dec 31, 2017 | 9.67% |
| Sep 30, 2017 | 7.57% |
| Jun 30, 2017 | 27.38% |
| Mar 31, 2017 | 22.29% |
| Dec 31, 2016 | 40.79% |
| Sep 30, 2016 | 7.49% |
| Jun 30, 2016 | 12.37% |
| Dec 31, 2015 | 7.14% |